Glaucoma is the disease most commonly associated with intraocular pressure (IOP). However, IOP is arguably the second-most critical metric next to visual acuity for assessing the ocular health of an individual. Therefore, accurate, repeatable, and interpatient comparable measurements of IOP often are helpful and occasionally critical for the treatment of all ocular disease processes as well as for routine screening exams by any eye care professional. Intraocular pressure measurement not only is critical to the accurate diagnosis of ocular disease, but also is a necessary guide to effective treatment strategies. The IOP is assessed routinely on the majority of patient visits to eye care professionals, including ophthalmologists and optometrists, which total approximately 50,000 in the United States and approximately 450,000 worldwide.
1,2 Glaucoma alone is a chronic and potentially debilitating disease requiring lifelong treatment. This disease currently affects 2.2 million Americans, with 3.3 million more expected by the year 2020. Glaucoma is now the leading cause of blindness in the aging Hispanic and African American populations, and nearly three times as common in African Americans as in White Americans. Worldwide, there were 60.5 million people with various types of glaucoma in 2010; this figure is expected to increase to 79.6 million by 2020.
3 Patients still go blind and suffer significant debilitating vision loss from glaucoma due to misdiagnosis and mismanagement.
4
For almost 60 years, Goldmann applanation tonometry (GAT) remains the standard for measurement of IOP.
5,6 Numerous significant errors in the GAT IOP measurements (mm Hg) have been described previously. Those errors are due to patient variability in corneal thickness (±7 mm Hg), corneal rigidity (±8 mm Hg), corneal curvature (±2 mm Hg), and corneal tear film (±5 mm Hg).
7–9 The combined errors of patient variable parameters are potentially sight threatening to a large population of patients, such as those with glaucoma or undiagnosed ocular hypertension from other causes, yet currently this is the best method we have clinically. Despite the inherent shortcomings identified in the GAT, nothing has improved upon its accuracy, cost-effectiveness, and ease of use. This problem was brought into the spotlight by the findings of the Ocular Hypertension Treatment Study (OHTS), which noted that pressure readings tend to be overestimated in thick, and underestimated in thinner, corneas. These errors lead to a misdiagnosis of glaucoma.
10 Since the OHTS findings, the standard of practice has changed to include a measurement of central corneal thickness (CCT) with a nomogram to correct the pressure for the CCT. Additionally, the effects of laser-assisted in situ keratomileusis (LASIK) surgery render accurate IOP measurement by the GAT problematic.
11 The CCT correction has been partially effective but unreliable due to the other potential corneal biomechanical and tear film errors. Attempts were made to measure and quantify the various error components to correct the GAT measurement and yield a standard IOP reading comparable between patients.
12 However, the process in practice is error prone and cumbersome, leading to very limited clinical adoption with the exception of CCT. Other direct measurements of IOP that potentially reduce error have been developed, such as the dynamic contour tonometer (DCT) which provides for a constant appositional force of 1 g on a concave surface, which contains a central miniaturized piezoresistive pressure sensor. This device is very similar to a tonopen tonometer but adds the constant 1 g of force which partially negates biomechanical errors by allowing the corneal deformation force to be partly resisted by the portion of the contact surface that does not measure IOP. The DCT similar to the error correcting noncontact ocular response analyzer (ORA) is not widely used and has had minimal clinical acceptance for routine IOP measurement.
Central corneal thickness or corneal thickness in general is a geometric quantity affecting the rigidity of the cornea.
8 The cornea is assumed by the Imbert-Fick principle to be an infinitely thin membrane that by definition has no shear rigidity, only strength in tension.
5,8 The “rigidity” of the cornea also is affected by the corneal curvature. A steeply curved cornea must be “bent” more to applanate against the tonometer prism overestimating the IOP. Conversely a flat cornea, such as in someone who has had LASIK, underestimates the IOP. Also, the intrinsic material property of the cornea (the modulus of elasticity – both Young's and shear) greatly affect the “rigidity” of the cornea.
13–15 All of these rigidity-affecting components together increase the force on the tonometer prism, which is attributed to IOP but, in fact, have no direct relation to IOP, hence the error. Finally, attraction created by the surface tension in the tear film (which also is extremely variable in patients) was theorized to negate much of the “rigidity” error.
16,17 However, no clinical quantification of this highly variable attractive capillary force has been demonstrated in its effect on IOP.
The CATS tonometer prism is a modification of the GAT prism. The CATS prism optimizes the corneal applanating surface of the flat surface GAT prism. The function of the CATS prism, including force to pressure conversion supplied by the GAT armature, remains unchanged. The optimized CATS prism is designed to measure the same pressure as GAT prism under “nominal” conditions. The “nominal” conditions include a standard average corneal thickness, curvature, rigidity, and tear film. However, approximately 50% of the patient population do not have a “nominal” cornea.
7,9,10,12 In these patients, the variability in each of these parameters induces significant individual and combined error in GAT IOP measurement, as mentioned previously.
7–9 Even the errors due to corneal thickness alone, which is but a fraction of the total error, are sight threatening.
10 For this reason, CCT correction was adopted as a standard of practice.
10 Although several other separate measurements and error corrections were proposed, they have been too cumbersome to be adopted clinically.
12 The CATS tonometer prism, illustrated in
Figures 1 and
2, can significantly reduce all of the identified measurement errors using the exact same measurement apparatus (with a modified prism), practitioner protocol, and measurement technique without calculations, increased time, and at minimal cost.